徳島大学 教育・研究者情報データベース(EDB)

1. 後藤 正和([徳島大学.大学院医歯薬学研究部.医学域.先端医学教育研究プロジェクト]/[徳島大学.大学院医歯薬学研究部.医学域.医科学部門.外科系.胸部・内分泌・腫瘍外科学])

   役割	任意
   貢献度	任意
   学籍番号	推奨

2. 沖津 宏

   役割	任意
   貢献度	任意
   学籍番号	推奨

3. (英) Yuasa Yasuhiro

   役割	任意
   貢献度	任意
   学籍番号	推奨

4. (英) Kuramoto Shunsuke

   役割	任意
   貢献度	任意
   学籍番号	推奨

5. (英) Tomibayashi Atsushi

   役割	任意
   貢献度	任意
   学籍番号	推奨

6. 松本 大資

   役割	任意
   貢献度	任意
   学籍番号	推奨

7. (英) Masuda Yuri

   役割	任意
   貢献度	任意
   学籍番号	推奨

8. (英) Edagawa Hiroshi

   役割	任意
   貢献度	任意
   学籍番号	推奨

9. (英) Tani Ryotaro

   役割	任意
   貢献度	任意
   学籍番号	推奨

10. (英) Mori Osamu

    役割	任意
    貢献度	任意
    学籍番号	推奨

11. (英) Matsuo Yuta

    役割	任意
    貢献度	任意
    学籍番号	推奨

(英) Short-Term Outcomes of Laparoscopic Distal Gastrectomy for Advanced Gastric Cancer.

(英) The purpose of this study was to investigate the oncologic outcomes of laparoscopic distal gastrectomy (LDG) for advanced gastric cancer (AGC). Between April 2003 and March 2014, LDG was performed for 392 patients, 91 patients (23.2%) had histopathologically diagnosed AGC beyond T2 depth. The clinicopathological features, postoperative outcomes, mortality, morbidity, recurrence rate, and survivals of those patients were reviewed. The TNM stages of the tumor were IB in 26 patients (28.5%), IIA in 20 (21.9%), IIB in 18 (19.7%), IIIA in 13 (14.2%), IIIB in 6 (6.5%), IIIC in 6 (6.5%), and IV in 2 (2.1%). Major morbidity occurred in 14 patients (15.3%), with no postoperative mortality. Median follow-up was 24.5 months; 10 patients developed recurrence during the follow-up period, and 10 patients died, including 6 cancer deaths. The 5-year overall and disease-free survival rates were 76.8% and 72.6%, respectively. By stage, OS/DFS was 92.3%/91.8% in stage IB, 85.4%/85.4% in stage II, and 49.3%/26.9% in stage III. Oncologic outcomes were good in patients with AGC, especially with stage IB-IIB, who underwent LDG. LDG appears to be an effective approach for treating stage IB and II gastric cancer.

1. (英) PublicationType: Journal Article